Recent research from the University of Helsinki sheds new light on the behavior of the KRAS gene in two of the deadliest cancers—pancreatic and colorectal cancer.
Graviton secures strategic investment from Sanofi
Share this article Sanofi’s strategic investment in Graviton Bioscience will advance the development of ROCK2 inhibitors. Credit: Gorodenkoff / Shutterstock.com. Graviton Bioscience has secured a